⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15492 | 1.00 | — | — | |
| SCHEMBL183086 | 1.00 | — | — | |
| SCHEMBL164203 | 1.00 | — | — | |
| SCHEMBL1711523 | 1.00 | LMNA (0.50) | — | |
| SCHEMBL10186511 | 1.00 | — | — | |
| SCHEMBL6752631 | 1.00 | — | — | |
| SCHEMBL334764 | 1.00 | — | — | |
| SCHEMBL18622757 | 0.94 | LMNA (0.46) | — | |
| SCHEMBL9576712 | 0.94 | LMNA (0.46) | — | |
| SCHEMBL4269830 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119325474-A | Spleen tyrosine kinase inhibitors | 尤尼奎斯特公司 | 2025-01-17 | — | — | CN | disclosed |